Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A clinical trial update indicates Phase 1/Phase 2 studies are investigating intravenous immunoglobulin–based therapy targeting collagen VII …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa [Phase 3]
A Phase 3 clinical trial evaluating SD-101 for Epidermolysis Bullosa is not yet recruiting, indicating ongoing development and pending enrol…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa [Phase 3]
An open-label extension safety study of SD-101 for Epidermolysis Bullosa is planned (Phase 3) and currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: FARD (RaDiCo Cohort) (RaDiCo-FARD)
The RaDiCo-FARD clinical trial sponsored by INSERM is currently recruiting, studying a cohort of patients with inherited skin and ectodermal…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Thera-Clean® Microbubbles System in Patients With Skin Diseases [EARLY_Phase 1]
Northwestern University is enrolling participants in an early-phase 1 trial of the Thera-Clean Microbubbles System for skin diseases, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study [Phase 2]
This is a Phase 2 clinical trial update for TCP-25 Gel in patients with epidermolysis bullosa, including dystrophic and junctional forms. Th…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds [NA]
A multicenter, randomized non-inferiority trial is comparing Debrisoft Duo with Debrisoft Pad for wound debridement, with recruitment ongoin…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa [Phase 3]
Phase 3 clinical trial in Japanese patients with epidermolysis bullosa to evaluate the safety and efficacy of Oleogel-S10. Recruitment is on…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) [Phase 3]
Phase 3 clinical trial evaluating allogeneic ABCB5-positive dermal mesenchymal stromal cells for epidermolysis bullosa; the study is current…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
A clinical trial update from Amryt Pharma about a study to assess the incidence of skin cancers in patients with epidermolysis bullosa recei…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients [Phase 3]
A Phase 3b trial of EB-101 for recessive dystrophic epidermolysis bullosa (DEB) in new and previously EB-101 treated patients is active but …
-
CLINICAL_TRIALS research · 2025-06-09Clinical Trial Update: Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) [Phase 1, Phase 2]
A clinical trial update evaluating efgartigimod alfa (Vyvgart) to treat bullous diseases by targeting collagen VII antibodies in Epidermolys…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Maastricht University Medical Center is conducting a qualitative study to explore reproductive counseling for patients with genodermatoses a…
-
CLINICAL_TRIALS research · 2024-04-03Clinical Trial Update: Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigated biochemical correction of severe Epidermolysis Bullosa using allogeneic hematopoietic stem cell tran…
-
CLINICAL_TRIALS research · 2017-08-24Clinical Trial Update: Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa
This completed clinical trial update describes a survey designed to identify burdens and unmet needs of patients with Epidermolysis Bullosa.